Fuse Science, Inc. is a clinical-stage biotechnology company focused on developing and commercializing ultrasound-mediated targeted drug delivery platforms. The company’s proprietary approach leverages microbubble and nanobubble-based contrast agents activated by focused ultrasound to enhance the precision and efficacy of therapeutic and imaging agents. By combining proprietary bubble formulations with advanced acoustic delivery systems, Fuse Science aims to improve drug uptake in target tissues, reduce systemic exposure, and expand the utility of existing pharmaceutical compounds across multiple therapeutic areas.
Originally founded with a vision to translate academic ultrasound research into viable commercial therapies, Fuse Science has since advanced several product candidates through preclinical development and into human trials. The company’s lead programs encompass oncology and neurology indications, where localized delivery of chemotherapeutic and neuroprotective agents has shown early promise. In oncology, Fuse Science is exploring applications in solid tumor treatment by increasing intratumoral drug concentrations, while in neurology it is evaluating blood–brain barrier modulation to facilitate delivery of large-molecule therapies for neurodegenerative disorders.
Founded in Texas and now headquartered in Houston, Fuse Science operates in the United States with research collaborations and clinical partnerships extending into Europe and Asia. The company maintains manufacturing alliances to support scalable production of its specialized contrast agents and ultrasound delivery devices. Through strategic academic and industry collaborations, Fuse Science continues to refine its platform technologies and expand its pipeline into additional indications such as cardiovascular disease and immunotherapy enhancement.
Fuse Science’s leadership team combines expertise in ultrasound physics, pharmaceutical development, and regulatory affairs. The executive management includes seasoned professionals who have guided multiple medical device and biopharmaceutical companies through clinical development and regulatory approvals. Supported by a board of directors with backgrounds in life sciences investing and translational research, Fuse Science is positioned to advance its proprietary drug delivery systems toward commercialization and strategic partnerships with global healthcare organizations.
AI Generated. May Contain Errors.
Free DROP Stock Alerts